Regulus Therapeutics Stocks List

Recent Signals

Date Stock Signal Type
2019-10-18 APTX 20 DMA Resistance Bearish
2019-10-18 CBAY MACD Bullish Signal Line Cross Bullish
2019-10-18 CBAY Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 CBAY 1,2,3 Retracement Bearish Bearish Swing Setup
2019-10-18 KOD New Uptrend Bullish
2019-10-18 KOD Upper Bollinger Band Walk Strength
2019-10-18 KOD NR7 Range Contraction
2019-10-18 KOD Slingshot Bullish Bullish Swing Setup
2019-10-18 MGEN Calm After Storm Range Contraction
2019-10-18 PRQR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 RGLS 20 DMA Support Bullish
2019-10-18 RGLS MACD Bullish Signal Line Cross Bullish
2019-10-18 SPRO Bollinger Band Squeeze Range Contraction
2019-10-18 SPRO Fell Below 200 DMA Bearish
2019-10-18 SPRO 20 DMA Support Bullish
2019-10-18 TBIO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 TBIO 180 Bearish Setup Bearish Swing Setup
2019-10-18 TORC Bullish Engulfing Bullish
2019-10-18 TORC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 UMRX Fell Below 20 DMA Bearish

Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.

More about Regulus Therapeutics